{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=87", "query": { "intervention": "Part 3", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 4023, "total_pages": 403, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=86&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T18:09:15.142Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07277413", "title": "A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "NSCLC Adenocarcinoma", "Gastroesophageal Cancer (GC)", "Gastric Adenocarcinoma", "Adenocarcinoma of Esophagus", "Squamous Cell Car. - Esophagus", "Urothelial Carcinoma (UC)", "Bladder Cancer", "Mesothelioma", "Pleural Mesothelioma", "Peritoneal Mesothelioma", "Non-Small Cell Lung Cancer NSCLC", "Pancreatic Cancer", "Biliary Tract Carcinoma" ], "interventions": [ { "name": "IDE892", "type": "DRUG" }, { "name": "IDE397", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "IDEAYA Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 260, "start_date": "2026-03-04", "completion_date": "2028-04-30", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 23, "location_summary": "Goodyear, Arizona • Phoenix, Arizona • Duarte, California + 19 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07277413" }, { "nct_id": "NCT02361346", "title": "Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-Hodgkin's B-cell Lymphoma", "Leukemia, Lymphocytic, Chronic, B-Cell", "Small Lymphocytic Leukemia", "Diffuse Large B Cell Lymphoma", "Blood Cancer", "Hematological Malignancy" ], "interventions": [ { "name": "MT-3724 Phase 1", "type": "DRUG" }, { "name": "MT-3724 Phase 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Molecular Templates, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2015-02", "completion_date": "2021-03-22", "has_results": true, "last_update_posted_date": "2022-08-18", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 17, "location_summary": "Tucson, Arizona • Whittier, California • Jacksonville, Florida + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Whittier", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02361346" }, { "nct_id": "NCT01835561", "title": "Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Clinical Pharmacology, Healthy Volunteer Study" ], "interventions": [ { "name": "Pomalidomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "18 Years to 70 Years · Male only" }, "enrollment_count": 32, "start_date": "2013-03-01", "completion_date": "2014-08-21", "has_results": false, "last_update_posted_date": "2019-11-12", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 2, "location_summary": "Orlando, Florida • Minneapolis, Minnesota", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01835561" }, { "nct_id": "NCT03434327", "title": "Training and Parkinson's", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease", "Weight-Lifting Exercise Program" ], "interventions": [ { "name": "Strength Training", "type": "OTHER" }, { "name": "Power Training", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "40 Years to 89 Years" }, "enrollment_count": 35, "start_date": "2018-02-01", "completion_date": "2018-08-15", "has_results": false, "last_update_posted_date": "2018-09-07", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 1, "location_summary": "Coral Gables, Florida", "locations": [ { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03434327" }, { "nct_id": "NCT01748760", "title": "Coping Long Term With Attempted Suicide - Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide" ], "interventions": [ { "name": "CLASP-A intervention", "type": "BEHAVIORAL" }, { "name": "Treatment as Usual", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Years to 18 Years" }, "enrollment_count": 50, "start_date": "2012-10", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2017-01-13", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT01748760" }, { "nct_id": "NCT04656080", "title": "Cardiopulmonary Stress Testing (CPET) AlloSure Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure", "Transplant; Failure, Heart" ], "interventions": [ { "name": "CPET exercise testing", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2020-05-21", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04656080" }, { "nct_id": "NCT01859858", "title": "Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Colorectal Cancer" ], "interventions": [ { "name": "curcumin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Irinotecan", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "21 Years to 99 Years" }, "enrollment_count": 23, "start_date": "2013-06", "completion_date": "2016-10-05", "has_results": false, "last_update_posted_date": "2023-12-04", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 2, "location_summary": "Indianapolis, Indiana • Chapel Hill, North Carolina", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01859858" }, { "nct_id": "NCT04435691", "title": "Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia" ], "interventions": [ { "name": "Azacitidine", "type": "DRUG" }, { "name": "Magrolimab", "type": "BIOLOGICAL" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2020-07-28", "completion_date": "2025-03-25", "has_results": true, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04435691" }, { "nct_id": "NCT06252220", "title": "First in Human Study in Subjects With Obesity, But Otherwise Healthy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "DA-1726", "type": "DRUG" }, { "name": "Placebo to DA-1726", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroBo Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 139, "start_date": "2024-03-25", "completion_date": "2026-11-09", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06252220" }, { "nct_id": "NCT04155580", "title": "A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "ASTX660", "type": "DRUG" }, { "name": "ASTX727", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astex Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2020-06-12", "completion_date": "2022-01-14", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-11-12T18:09:15.142Z", "location_count": 15, "location_summary": "San Francisco, California • New Haven, Connecticut • Miami, Florida + 11 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04155580" } ] }